Meningococcal meningitis control in Iran: Five year comparative study 2000-2004

Journal of Medical Sciences

Volumn 9, Issue 1, 2009, Pages 51-54

  Tavana, A Mehrabi ^a   Ataee, R A ^a  

^a BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Intervation; Meningococcal vaccination; Neisseria meningitidis; Time

Indexed keywords

MENINGOCOCCUS VACCINE;

ADOLESCENT; ADULT; ARMY; ARTICLE; CEREBROSPINAL FLUID CULTURE; CHILD; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFICACY; EPIDEMIC MENINGITIS; FEMALE; HUMAN; INCIDENCE; INFANT; INFECTION CONTROL; IRAN; MAJOR CLINICAL STUDY; MALE; MASS IMMUNIZATION; MORTALITY; TREND STUDY;

EID: 67649503140     PISSN: 16824474     EISSN: 18125727     Source Type: Journal    
DOI: 10.3923/jms.2009.51.54     Document Type: Article

References (18)

1. Ataee, R.A., T.A. Mehrabi, G.H. Ghorbani, S.A. Mosavi, Z.A. Karimi and M. Hajia, 2005. Recurrent mennigococcal meningitidis in an Iranian conscript: A brief report. Clin. Microbiol. Newsletter, 27: 136-137.
2. Booy, R., M. Isklander, Viner, S.N. Senanayake and P. Gardner, 2007. Prevention of mening ococcal disease. N. Engl. J. Med., 356: 1466-1473.
3. Butler, K.M., 2006. Meaningococcal meningitis prevention program for college students: A review of the literature. Worldviews Evid. Based Nurs., 316: 186-193.
4. Cardinale, V., Drug Topics Red Book. Medical Economics Co. Inc., Montvale, New Jersey.
5. Department of Defense, 2000. Meningococcal disease among soldiers, US army, 1964-1998. Med. Surveill Mon. Rep., 6: 2-3.
6. Esposito, S., A. Lizioli, A. Lastrico, E. Begliatti and A. Rognoni et al., 2007. Impact on respiratory tract infections of heptavalent pneumococcal conjugate vaccine administered at 3, 5 and 11 months of age. Respir. Res., 8: 12-12.
7. Jackson, L.A., A, Schuchat, R.D. Gorsky and J.D. Wenger, 1995. Should college students be vaccinated against meningococcal disease? A cost-benefit analysis. Am. J. Public Health, 85: 843-845.
8. Janet M.M. and T.C. Karen, 1999. Host Genes and Infectious Disease HIV, Other Pathogens and a Public Health Perspective. Am. J. Pre. Med., 16: 241-254.
9. Manchanda, V., S. Gupta and P. Bhalla, 2006. Meningococcal disease: History, epidemiology, pathogenesis, clinical manifestations, diagnosis, antimicrobial susceptibility and prevention. Ind. J. Med. Microbiol., 24: 7-19.
10. Mayon-White, R.T. and P.T. Heath, 1997. Preventive strategies on meningococcal disease. Arch. Dis. Child, 76: 178-181.
11. Pollard, A.J. and M. Levin, 2000. Vaccines for prevention of meningococcal disease. Pediatr. Infect. Dis. J., 19: 333-345.
12. Puricelli, B.C.R., E. Kupek and B.H.M. Westrupp, 2004. Three decates of meningococcal disease in the State of Santa Catarina, Brazil. Braz. J. Infect. Dis., 3: 1-8.
13. Rendi-Wagner, P., E. Jeschko, H. Kollaritsch and O.E.F. Reisemedizin, 2005. Travel vaccination recommendations for Central and Eastern European countries based on country-specific risk profiles. Wien. Klin. Wochenschr., 117: 11-19.
14. Riedo, F.X., B.D. Plikaytis and C.V. Broome, 1995. Epidemiology and prevention of meningococcal disease. Pediatr. Infect. Dis. J., 14: 643-657.
15. Rosenstein, N.E., B.A. Perkins, D.S. Stephens and H.M. Popovic, 2001. Meningococcal disease. New Engl. J. Med., 344: 1378-1388.
16. Singurdadottir, B., O.M. Björnsson, K.E. Jónsdóttir, H. Erlendsdóttir and S. Gudmundsson, 1997. Acute bacterial meningitis in adults: A 20 year overview. Arch. Intern. Med., 157: 425-430.
17. Siu, T., Tang, M. Dawar and D.M. Patrick, 2008. The impact of routine immunization using meningococcal C conjugate vaccine on invasive meningococcal disease in British Columbia. Can. J. Public Health, 99: 380-382.
18. Smith, M.J., 2008. Meningococcal tetravalent conjugate vaccine. Expert Opin. Biol. Ther., 8: 1941-1946.